GlassScriptPhysician profile
Shane Ryan Speirs
NPI 1427589498
$2,389.25
in general payments reported to CMS, 2019-2025
14 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $82.23 · 2022: $1,246 · 2023: $590 · 2024: $334 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,061.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,060.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,202.46 | 2022-2025 | Therasphere Y90 Glass Microspheres 7.0 Gbq (US Commercial), General - Angiography, Avista Mri |
| Lucid Diagnostics INC. | $370.73 | 2022 | |
| Angiodynamics, INC. | $234.81 | 2023 | Auryon Laser System 100-120 Vac |
| Covis Pharma Gmbh | $144.89 | 2021-2022 | |
| Siemens Medical Solutions USA, INC. | $79.75 | 2022 | |
| Biotronik INC. | $76.92 | 2023 | Pulsar-18 T3 |
| Novo Nordisk INC | $73.17 | 2022-2024 | Rybelsus, Ozempic |
| Pfizer INC. | $58.02 | 2024 | |
| Medtronic, INC. | $41.31 | 2022 | |
| Bardy Diagnostics, INC. | $30.12 | 2022 | |
| Abbott Laboratories | $23.83 | 2023 | Proclaim |
| Sanofi-Aventis U.S. LLC | $18.82 | 2022 | |
| Lilly USA, LLC | $17.40 | 2023 | Mounjaro |
| Corcept Therapeutics | $17.02 | 2024 | Korlym |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shane Speirs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.